Kalaris Therapeutics, Inc. (KLRS) Net Income by Year
Kalaris Therapeutics, Inc. reported a net loss of $43.4M in fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Kalaris Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KLRS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
KLRS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Kalaris Therapeutics, Inc. financials
Frequently Asked Questions
What was Kalaris Therapeutics, Inc.'s net income in fiscal year 2025?
Kalaris Therapeutics, Inc. reported a net loss of $43.4M in fiscal year 2025.
How has Kalaris Therapeutics, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Kalaris Therapeutics, Inc. (KLRS) net income went from -$23.8M in fiscal year 2019 to -$43.4M in fiscal year 2025.
What was Kalaris Therapeutics, Inc.'s net income in the most recent quarter?
Kalaris Therapeutics, Inc. (KLRS) reported -$11.5M in net income in Q2 2026. This represents a decrease of 1.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Kalaris Therapeutics, Inc. (KLRS) reported on that line in every period on record.